Incyte Corporation
Commercial biopharma with core hematology, oncology and inflammation franchises and multiple pivotal-stage assets.
Hematology, oncology & inflammation · Small molecules and monoclonal/bispecific antibodies · Commercial + Phase 3
Commercial biopharma with core hematology, oncology and inflammation franchises and multiple pivotal-stage assets.
Hematology, oncology & inflammation · Small molecules and monoclonal/bispecific antibodies · Commercial + Phase 3